your market intelligence analyst
Search Results
306 results
Your search is now limited to «Hypertension» expert search. 01/28/2020 06:24
It's established that elevated blood pressure in the body can lead to damage in the arteries of both the body and the brain.
More from
Acceleron Pharma’s investigational treatment for pulmonary arterial hypertension showed positive outcomes in a mid-stage trial, the company announced on Monday.
More from RT: For Decision Makers in Respiratory Care:
MarketWatch 01/27/2020 16:22
Acceleron said a Phase 2 clinical trial showed its drug sotatercept had a statistically significant reduction in pulmonary vascular resistance in patients with pulmonary arterial hypertension compared with placebo.
More from MarketWatch:
Business Wire 01/27/2020 16:01
Acceleron is developing sotatercept for the treatment of pulmonary arterial hypertension, having recently reported positive topline results of the Phase 2 PULSAR trial and actively enrolling patients in the Phase 2 SPECTRA trial.
More from Business Wire: 01/27/2020 13:40
Smoking jeopardizes the body’s ability to self regulate blood pressure, causing abnormal spikes in blood pressure that lead to hypertension.
More from 01/27/2020 12:00
Pulmonary Arterial Hypertension has gone from a disease that causes rapid death to a more chronic condition.
More from
ENDPOINTS 01/27/2020 10:01
On the same day that it’s getting back an experimental from AbbVie and Allergan’s pre-merger divestiture exercise, AstraZeneca has engineered a sale of its own. The pharma giant is collecting from Atnahs Pharma for global commercial rights to a suite of five off-patent hypertension drugs: Inderal (propranolol), Tenormin (atenolol), Tenoretic (atenolol, chlorthalidone fixed-dose combination), Zestril (lisinopril) and Zestoretic (lisinopril, hydrochlorothiazide fixed-dose combination). Together, they generated sales of $132 million in 2018 in the markets covered by the deal, which excluded the US, India and Japan, according to AstraZeneca.
Currently, Liquidia is focused on the development of two product candidates using its PRINT particle engineering platform: LIQ861 for the treatment of pulmonary arterial hypertension and LIQ865 for the treatment of local post-operative pain.
More from Middle East North Africa Financial Network (MENAFN):
FeedNavigator (EU) 01/24/2020 15:39
While previous studies have shown that self-report of hypertension or high blood pressure is typically consistent with clinical diagnoses or treatment for hypertension based on electronic medical record review [64], some studies have found under-reporting of hypertension status in 8 to 10 percent of cases ...
More from FeedNavigator (EU):
Neurology Advisor 01/24/2020 13:35
A comparative list of Angiotensin-Converting Enzyme (ACE) Inhibitors monotherapy and combination therapy for the treatment of hypertension. .
More from Neurology Advisor:

Therapeutic Areas

Clinical Trials and Phases

Business Issues

Companies - Public

Companies - Venture Funded

Financial Results

Global Markets

Global Risk Factors

Government Agencies

Job Titles

Legal and Regulatory

Cell Receptors


Diagnostics and Therapeutics


Drugs - Brand Names

Drugs - Generic



Health Care

Health and Wellness

Human Anatomy

Mechanisms of Action

Medical Devices



Strategic Scenarios



On this page, you see the results of the search you have run.  You may also view the following:

  •  Click on this drop-down menu on the right hand side of the page, to choose between the machine learning-produced Insights Reports, or the listing of concepts extracted from the results, in chart or list format. 

  •  View the number of search results returned for the search in each of your collections, and click on any of those numbers to view the entire listing of results from the chosen collection.

  •  Use the search adjustment drop-downs to change the scope, sorting, and presentation of your results.

  •  Show or hide the record’s caption (content description).

  •  Show actions that can be made with the search result record.

  •  Click on the Save button after running your search, to save it so that its results will be updated each time relevant new content is added to the designated collection. You may choose to be notified via search alerts.

Click here for more info on Search Results

Click here for more info on Machine Learning applications